RNAZ

TransCode Therapeutics Inc

May 19 • 02:48PM ET

6.28

+0.11 1.78 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IMNN BCDA SHPH HOTH ARTL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-48.65	Insider Own	9.08%	Shs Outstand	0.92M	Perf Week	-6.69%
Market Cap	5.96M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.83M	Perf Month	-29.32%
Enterprise Value	136.39M	PEG	-	EPS next Q	-	Inst Own	7.90%	Short Float	4.31%	Perf Quarter	-31.74%
Income	-43.70M	P/S	-	EPS this Y	-	Inst Trans	3.98%	Short Ratio	3.76	Perf Half Y	-32.03%
Sales	0.00M	P/B	4.60	EPS next Y	-	ROA	-47.38%	Short Interest	0.04M	Perf YTD	-8.05%
Book/sh	1.36	P/C	0.46	EPS next 5Y	-	ROE	-52.14%	52W High	20.99 -70.08%	Perf Year	-6.27%
Cash/sh	13.52	P/FCF	-	EPS past 3/5Y	96.25% 79.17%	ROIC	-27.93%	52W Low	6.02 4.32%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.89% 7.58%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	95.40%	Oper. Margin	-	ATR (14)	0.63	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.11	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	25.86	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.11	EPS Q/Q	69.67%	SMA20	-17.36%	Beta	1.38	Target Price	280.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-25.39%	Rel Volume	1.19	Prev Close	6.17
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	-35.29%	Avg Volume	9.50K	Price	6.28
IPO	Jul 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	67.35% -100.00%	Trades		Volume	9,369	Change	1.78%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)